The World Health Organization (WHO ... From both a medical and economic standpoint, the biopharmaceutical industry has grown extremely rapidly over the past two decades. The total number of ...

phase II and phase III clinical development by biopharmaceutical companies developing therapeutics, as well as all actions by global regulatory authorities and clinical data reported at industry ...

With global spending on prescription drugs ... Our latest report on the biopharmaceutical landscape analyzes industry themes, market share and concentration, ESG considerations, outlooks in ...